These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3143042)

  • 41. Antigenic and immunogenic properties of cyanogen bromide peptides from a serotype 5 gonococcal outer membrane protein I.
    Teerlink T; Versantvoort H; Beuvery EC
    Antonie Van Leeuwenhoek; 1987; 53(6):493-9. PubMed ID: 2453158
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neisserial surface variation: how and why?
    Swanson J; Belland RJ; Hill SA
    Curr Opin Genet Dev; 1992 Oct; 2(5):805-11. PubMed ID: 1360853
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of a gonorrhoea vaccine: prospects, strategies and tactics.
    Gotschlich EC
    Bull World Health Organ; 1984; 62(5):671-80. PubMed ID: 6150769
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Loss of both Holliday junction processing pathways is synthetically lethal in the presence of gonococcal pilin antigenic variation.
    Sechman EV; Kline KA; Seifert HS
    Mol Microbiol; 2006 Jul; 61(1):185-93. PubMed ID: 16824104
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Location of a blocking epitope on outer-membrane protein III of Neisseria gonorrhoeae by synthetic peptide analysis.
    Virji M; Heckels JE
    J Gen Microbiol; 1989 Jul; 135(7):1895-9. PubMed ID: 2482335
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The interaction of naturally elaborated blebs from serum-susceptible and serum-resistant strains of Neisseria gonorrhoeae with normal human serum.
    Pettit RK; Judd RC
    Mol Microbiol; 1992 Mar; 6(6):729-34. PubMed ID: 1574002
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of a cloned lipopolysaccharide antigen from Neisseria gonorrhoeae on the surface of Escherichia coli K-12.
    Palermo DA; Evans TM; Clark VL
    Infect Immun; 1987 Nov; 55(11):2844-9. PubMed ID: 3117695
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Surface-exposed antigenic cleavage fragments of Neisseria gonorrhoeae proteins 1A and IB.
    Schmitt S; Layh G; Buchanan TB
    Infect Immun; 1986 Dec; 54(3):841-5. PubMed ID: 3096894
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analyses of gonococcal H8 antigen. Surface location, inter- and intrastrain electrophoretic heterogeneity, and unusual two-dimensional electrophoretic characteristics.
    Hitchcock PJ; Hayes SF; Mayer LW; Shafer WM; Tessier SL
    J Exp Med; 1985 Dec; 162(6):2017-34. PubMed ID: 2415662
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proteomics-driven Antigen Discovery for Development of Vaccines Against Gonorrhea.
    Zielke RA; Wierzbicki IH; Baarda BI; Gafken PR; Soge OO; Holmes KK; Jerse AE; Unemo M; Sikora AE
    Mol Cell Proteomics; 2016 Jul; 15(7):2338-55. PubMed ID: 27141096
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetics of surface protein variation in Neisseria gonorrhoeae.
    Murphy GL; Cannon JG
    Bioessays; 1988 Jul; 9(1):7-11. PubMed ID: 3145742
    [No Abstract]   [Full Text] [Related]  

  • 52. Genetic mechanisms of bacterial antigenic variation.
    Seifert HS; So M
    Microbiol Rev; 1988 Sep; 52(3):327-36. PubMed ID: 2903434
    [No Abstract]   [Full Text] [Related]  

  • 53. [Protective properties of the gonococcal L-antigen].
    Andreeva ZM; Chaĭko GA; Shevchenko NM
    Vestn Dermatol Venerol; 1987; (4):34-7. PubMed ID: 3111117
    [No Abstract]   [Full Text] [Related]  

  • 54. Production of Neisseria gonorrhoeae pili (fimbriae) in Pseudomonas aeruginosa.
    Hoyne PA; Haas R; Meyer TF; Davies JK; Elleman TC
    J Bacteriol; 1992 Nov; 174(22):7321-7. PubMed ID: 1358873
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pilin gene variation in Neisseria gonorrhoeae: reassessing the old paradigms.
    Hill SA; Davies JK
    FEMS Microbiol Rev; 2009 May; 33(3):521-30. PubMed ID: 19396954
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Opacity genes in Neisseria gonorrhoeae: control of phase and antigenic variation.
    Stern A; Brown M; Nickel P; Meyer TF
    Cell; 1986 Oct; 47(1):61-71. PubMed ID: 3093085
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protein I (Por) of Neisseria gonorrhoeae as an immunogen: liposomes, proteosomes, and the lack of blocking antibodies.
    Wetzler LM; Blake MS; Gotschlich EC
    Trans Assoc Am Physicians; 1989; 102():78-90. PubMed ID: 2561644
    [No Abstract]   [Full Text] [Related]  

  • 58. Neisseria gonorrhoeae recombinant strains expressing hybrid serological reactivities of outer membrane proteins IA and IB.
    Shinners EN; Catlin BW
    J Infect Dis; 1988 Sep; 158(3):529-36. PubMed ID: 2457634
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sequence changes in the pilus subunit lead to tropism variation of Neisseria gonorrhoeae to human tissue.
    Jonsson AB; Ilver D; Falk P; Pepose J; Normark S
    Mol Microbiol; 1994 Aug; 13(3):403-16. PubMed ID: 7997158
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gonococcal MtrE and its surface-expressed Loop 2 are immunogenic and elicit bactericidal antibodies.
    Wang S; Xue J; Lu P; Ni C; Cheng H; Han R; van der Veen S
    J Infect; 2018 Sep; 77(3):191-204. PubMed ID: 29902495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.